Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.
about
Effective dose estimation for oncological and neurological PET/CT procedures.EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstructionEffect of Bayesian-penalized likelihood reconstruction on [13N]-NH3 rest perfusion quantification.EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.Effects of a novel tungsten-impregnated rubber neck shield on the quality of cerebral images acquired using (15)O-labeled gas.Reconstruction of uptake patterns in PET: The influence of regularizing prior.Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET.Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT.Status of cardiovascular PET radiation exposure and strategies for reduction: An Information Statement from the Cardiovascular PET Task Force.[18F]Fluoromisonidazole PET in rectal cancer.Software Respiratory Gating of Positron Emission Tomography-Computed Tomography Improves Pulmonary Nodule Detection.Diagnostic and response assessment FDG PET-CT in neurolymphomatosisEvaluation of lesion detectability in positron emission tomography when using a convergent penalized likelihood image reconstruction method.Effect of Time-of-Flight and Regularized Reconstructions on Quantitative Measurements and Qualitative Assessments in Newly Diagnosed Prostate Cancer With 18F-Fluorocholine Dual Time Point PET/MRI.Comparison of different automated lesion delineation methods for metabolic tumor volume of 18F-FDG PET/CT in patients with stage I lung adenocarcinoma.18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer.Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.Evaluation of principal component analysis based data driven respiratory gating for positron emission tomography.Standard OSEM vs. regularized PET image reconstruction: qualitative and quantitative comparison using phantom data and various clinical radiopharmaceuticals.Incidental finding of a breast carcinoma on Ga-68-DOTA-1-Nal3-octreotide positron emission tomography/computed tomography performed for the evaluation of a pancreatic neuroendocrine tumor: A case report
P2860
Q33599612-96A6F238-40AC-412E-B2C3-22F18F16B3E6Q33740261-6A1BAED7-9153-4CA5-A79A-627CE85B4638Q35935680-716FB049-073B-4C6F-A49D-F07222294C98Q37375799-A09BEF4A-6BE8-4A52-9633-5BF505F67C8AQ37433290-C4FB4F92-4690-4AF1-BD16-C1FD4059ED1AQ38617349-55191F56-E7B2-4ACF-8BD6-7F2CB54A5849Q38907593-F73AB4FF-E6D5-4433-A75C-074FEF4057F1Q39216200-05980B3E-9FB0-4BCC-A820-B4C1D77E73BCQ39422071-A7D1EF31-9489-4392-97DF-CF9D447DCB87Q39423472-66A44069-62D0-4289-A914-AEEB78957E34Q40209620-B7DEC110-49A7-42CF-B8F2-4896AA95C554Q42121596-D2D4BEDB-EFCD-4ED3-9616-DD3FE463E577Q42291168-CB05E126-50DD-4768-B335-852499762F90Q42359788-E4D7EE0B-0C11-4406-A83D-72CD4FD10DE4Q45943356-5ECB9F1A-3170-4E71-95D0-ACA1416D7588Q46423605-27D4F79D-DDD3-4463-9B74-C284E0ADA0CBQ47553437-57BEC86B-C1FB-4FC4-BB77-64EBFCB8FEC1Q48248991-B499C579-7A63-48E8-A7F3-79ECBA8F90CEQ48304602-A92CD8D8-A4B7-4494-ACB0-9AF31885690EQ50054096-42CFCAF8-BC5B-4327-9864-9B74D8C1B00EQ54966917-3A8C0FE6-B26C-45F6-9CFD-D29592C3D126Q57531622-821003B0-3FD0-44FC-8FE4-BA48663AAB25
P2860
Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phantom and Clinical Evaluatio ...... lear on an LYSO PET/CT System.
@ast
Phantom and Clinical Evaluatio ...... lear on an LYSO PET/CT System.
@en
type
label
Phantom and Clinical Evaluatio ...... lear on an LYSO PET/CT System.
@ast
Phantom and Clinical Evaluatio ...... lear on an LYSO PET/CT System.
@en
prefLabel
Phantom and Clinical Evaluatio ...... lear on an LYSO PET/CT System.
@ast
Phantom and Clinical Evaluatio ...... lear on an LYSO PET/CT System.
@en
P2860
P50
P1476
Phantom and Clinical Evaluatio ...... Clear on an LYSO PET/CT System
@en
P2093
Kevin M Bradley
Ruth E Macpherson
P2860
P304
P356
10.2967/JNUMED.115.159301
P407
P577
2015-07-09T00:00:00Z